TOI · NASDAQ · Medical - Care Facilities

The Oncology Institute (TOI)

Manages community cancer care with patient services, specialty pharmacy, and clinical trials.

$5.13
At close−1.26 (−19.72%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue82869599100100104120137142147161
Cost of revenue667183868686871021181191260
Gross profit16141213141517181923220
3030302928272729273028166
Selling, general & administrative000002525025282830
Other expenses30303029282229220136
Operating income−14−15−18−16−14−12−10−11−8−7−7−5
−3−4−21−2−1−10−6−8−14−5
Interest income100000000000
Interest expense322221622222
Other non-operating income000−300447−1−60
Income before tax−17−19−20−15−16−13−20−17−17−8−2−10
Income tax expense000000000000
Net income from continuing operations−17−19−20−15−16−13−20−17−17−8−2−10
Net income−17−19−20−15−16−13−20−17−17−8−2−10
EPS, basic−$0.19−$0.21−$0.22−$0.17−$0.18−$0.14−$0.21−$0.15−$0.14−$0.04−$0.02−$0.08
EPS, diluted−$0.19−$0.21−$0.22−$0.17−$0.18−$0.14−$0.21−$0.15−$0.14−$0.04−$0.02−$0.08
Weighted average shares, basic737374757676779329751,0151,0181,030
Weighted average shares, diluted737374757676779329751,0151,0181,030
EBITDA−12−14−16−12−12−10−12−13−13−41−3
Depreciation & amortization221222222222
EBIT−14−15−18−13−14−12−14−15−15−6−10